Luke J Laffin (Luke Laffin)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Hypertension (Dallas, Tex. : 1979)

Current cardiology reports

Clinical cardiology

European heart journal

Cleveland Clinic Foundation

University of Calgary (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cleveland Clinic Foundation Jul 23 2018

United States

Staff Physician - Preventive Cardiology :: Cardiovascular Disease

University of Chicago Jul 01 2015 - Jun 30 2018

United States

Fellow :: Cardiology

University of Chicago Jul 01 2014 - Jun 30 2015

United States

Fellow :: Hypertension

University of Chicago Department of Medicine Jun 24 2011 - Jun 30 2014

United States

Resident Physician :: Internal Medicine

Education History

University of Calgary Sep 01 2003 - Jun 01 2007

Canada

BSC :: Chemistry

Publications

James A de Lemos, Bruno Linetzky, Carel W le Roux, Luke J Laffin, Wanpen Vongpatanasin, Ludi Fan, Andrea Hemmingway, Nadia N Ahmad, Mathijs C Bunck, Adam Stefanski
Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m 2 : SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy. Hypertension (Dallas, Tex. : 1979) 81 (4) (2024)
Abhayjit Singh, Luke J Laffin, Ashish Sarraju, A Michael Lincoff, Stephen J Nicholls, LeAnne Bloedon, William J Sasiela, Na Li, Paula Robinson, Stephanie Kelly, Denise Mason, Steven E Nissen
Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes Trial. Clinical cardiology 47 (8) (2024)
Abhayjit Singh, Luke J Laffin, Ashish Sarraju, A Michael Lincoff, Stephen J Nicholls, LeAnne Bloedon, William J Sasiela, Na Li, Paula Robinson, Stephanie Kelly, Denise Mason, Steven E Nissen
Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes Trial. Clinical cardiology 47 (8) (2024)
Abhayjit Singh, Luke J Laffin, Ashish Sarraju, A Michael Lincoff, Stephen J Nicholls, LeAnne Bloedon, William J Sasiela, Na Li, Paula Robinson, Stephanie Kelly, Denise Mason, Steven E Nissen
Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes Trial. Clinical cardiology 47 (8) (2024)
James A de Lemos, Bruno Linetzky, Carel W le Roux, Luke J Laffin, Wanpen Vongpatanasin, Ludi Fan, Andrea Hemmingway, Nadia N Ahmad, Mathijs C Bunck, Adam Stefanski
Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m 2 : SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy. Hypertension (Dallas, Tex. : 1979) (2024)
James A de Lemos, Bruno Linetzky, Carel W le Roux, Luke J Laffin, Wanpen Vongpatanasin, Ludi Fan, Andrea Hemmingway, Nadia N Ahmad, Mathijs C Bunck, Adam Stefanski
Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m 2 : SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy. Hypertension (Dallas, Tex. : 1979) 81 (4) (2024)
James A de Lemos, Bruno Linetzky, Carel W le Roux, Luke J Laffin, Wanpen Vongpatanasin, Ludi Fan, Andrea Hemmingway, Nadia N Ahmad, Mathijs C Bunck, Adam Stefanski
Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m 2 : SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy. Hypertension (Dallas, Tex. : 1979) 81 (4) (2024)
James A de Lemos, Bruno Linetzky, Carel W le Roux, Luke J Laffin, Wanpen Vongpatanasin, Ludi Fan, Andrea Hemmingway, Nadia N Ahmad, Mathijs C Bunck, Adam Stefanski
Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m 2 : SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy. Hypertension (Dallas, Tex. : 1979) 81 (4) (2024)
Joseph Kassab, Joseph El Dahdah, Michel Chedid El Helou, Habib Layoun, Ashish Sarraju, Luke J Laffin, Leslie Cho, Samir R Kapadia, Patrick H Collier, Serge C Harb
Assessing the Accuracy of an Online Chat-Based Artificial Intelligence Model in Providing Recommendations on Hypertension Management in Accordance With the 2017 American College of Cardiology/American Heart Association and 2018 ESC/European Society of Hypertension Guidelines. Hypertension (Dallas, Tex. : 1979) (2023)
Luke J Laffin, Dennis Bruemmer, Steven E Nissen
Are dietary supplements beneficial in lowering cholesterol? SPORT reflections and the path forward. European heart journal 44 (8) (2023)
Saeid Mirzai, Luke J Laffin
Supplements for Lipid Lowering: What Does the Evidence Show? Current cardiology reports (2023)
Jonathan D Ravid, Luke J Laffin
Effects of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, on Cardiovascular Disease, Chronic Kidney Disease, and Blood Pressure. Current cardiology reports 24 (10) (2022)
Luke J Laffin, Dennis Bruemmer, Steven E Nissen
Are dietary supplements beneficial in lowering cholesterol? SPORT reflections and the path forward. European heart journal (2022)
Luke J Laffin, Harvey W Kaufman, Zhen Chen, Justin K Niles, Andre R Arellano, Lance A Bare, Stanley L Hazen
Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic. Circulation (2021)
Ben Alencherry, Luke J Laffin
Treatment of Hypertension in Patients with Diabetes Mellitus: a Contemporary Approach. Current cardiology reports 23 (3) (2021)
Luke J Laffin, Asad Khan, Katherine Lang, Erik H Van Iterson
Prevalence and clinical outcomes of patients with apparent treatment-resistant hypertension enrolled in Phase 2 cardiac rehabilitation. Journal of clinical hypertension (Greenwich, Conn.) 22 (12) (2020)

Luke J Laffin.css-eqlu8i{font-size:small;padding-left:4px;} (Luke Laffin)

Publication Activity (10 Years)

Top Topics

Top Venues

Luke J Laffin (Luke Laffin)